UNSPSC 51342316: Valganciclovir hydrochloride

This classification denotes the hydrochloride form of a purine antagonist and antiviral agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GCU97FKN3R. European Medicines Agency schedules Valganciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00007MIG. Valganciclovir generally arises in the molecular formula C14H22N6O5.

UNSPSC 51342316 Valganciclovir hydrochloride is a Commodity code for an antiviral pharmaceutical product. State and local governments purchasing under this code are acquiring branded or generic pharmaceutical inventory for public health, corrections, and institutional care programs. The code captures individual drug products procured through pharmaceutical supply contracts, often leveraging group purchasing organization (GPO) piggyback agreements and cooperative purchasing vehicles to achieve volume pricing. Issuing bodies include state departments of public health, county health departments, and special-purpose health districts that maintain pharmaceutical stockpiles or supply institutional care settings.

Recent state and local opportunities under this code show limited posted activity. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic products (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), with a total award of $2,999,999.11 over three years including renewals; however, this record does not reflect an active solicitation. Seminole County, Florida posted an IFB in June 2026 for Naloxone and Safe Drug Deactivation Systems, with quarterly deliveries required to the county's Community Health Building in Sanford. The recent opportunities do not represent a sustained procurement pipeline under this specific UNSPSC code—most pharmaceutical purchasing by state and local agencies occurs through standing GPO contracts, cooperative purchasing catalogs, and blanket orders rather than discrete solicitations tagged to individual drug products.